The next opportunity in anti-malaria drug discovery: the liver stage.
Publication
, Journal Article
Derbyshire, ER; Mota, MM; Clardy, J
Published in: PLoS pathogens
September 2011
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
PLoS pathogens
DOI
EISSN
1553-7374
ISSN
1553-7366
Publication Date
September 2011
Volume
7
Issue
9
Start / End Page
e1002178
Related Subject Headings
- Virology
- Plasmodium malariae
- Malaria
- Liver
- Humans
- Drug Resistance, Microbial
- Drug Discovery
- Chloroquine
- Artemisinins
- Antimalarials
Citation
APA
Chicago
ICMJE
MLA
NLM
Derbyshire, E. R., Mota, M. M., & Clardy, J. (2011). The next opportunity in anti-malaria drug discovery: the liver stage. PLoS Pathogens, 7(9), e1002178. https://doi.org/10.1371/journal.ppat.1002178
Derbyshire, Emily R., Maria M. Mota, and Jon Clardy. “The next opportunity in anti-malaria drug discovery: the liver stage.” PLoS Pathogens 7, no. 9 (September 2011): e1002178. https://doi.org/10.1371/journal.ppat.1002178.
Derbyshire ER, Mota MM, Clardy J. The next opportunity in anti-malaria drug discovery: the liver stage. PLoS pathogens. 2011 Sep;7(9):e1002178.
Derbyshire, Emily R., et al. “The next opportunity in anti-malaria drug discovery: the liver stage.” PLoS Pathogens, vol. 7, no. 9, Sept. 2011, p. e1002178. Epmc, doi:10.1371/journal.ppat.1002178.
Derbyshire ER, Mota MM, Clardy J. The next opportunity in anti-malaria drug discovery: the liver stage. PLoS pathogens. 2011 Sep;7(9):e1002178.
Published In
PLoS pathogens
DOI
EISSN
1553-7374
ISSN
1553-7366
Publication Date
September 2011
Volume
7
Issue
9
Start / End Page
e1002178
Related Subject Headings
- Virology
- Plasmodium malariae
- Malaria
- Liver
- Humans
- Drug Resistance, Microbial
- Drug Discovery
- Chloroquine
- Artemisinins
- Antimalarials